Squamous cell carcinoma of gallbladder and extrahepatic biliary tract
disease diseaseOn this page
Also known as squamous cell carcinoma of gallblader and EBT
Summary
Squamous cell carcinoma of gallbladder and extrahepatic biliary tract (MONDO:0018537) is a cancer. A subtype of extrahepatic bile duct squamous cell carcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
- Prevalence: <1 / 1 000 000 (Europe) [Orphanet-validated]
Clinical features
Epidemiology
Prevalence records
23 prevalence record(s), Orphanet, top 20 (validated / broadest geography first):
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Annual incidence | <1 / 1 000 000 | 0.032 | Europe | Validated |
| Annual incidence | <1 / 1 000 000 | 0.026 | Austria | Validated |
| Annual incidence | <1 / 1 000 000 | 0.006 | Belgium | Validated |
| Annual incidence | <1 / 1 000 000 | 0.027 | Bulgaria | Validated |
| Annual incidence | <1 / 1 000 000 | 0.025 | Croatia | Validated |
| Annual incidence | 1-9 / 1 000 000 | 0.124 | Czech Republic | Validated |
| Annual incidence | <1 / 1 000 000 | 0.037 | Estonia | Validated |
| Annual incidence | <1 / 1 000 000 | 0.026 | Finland | Validated |
| Annual incidence | <1 / 1 000 000 | 0.018 | France | Validated |
| Annual incidence | <1 / 1 000 000 | 0.055 | Germany | Validated |
| Annual incidence | <1 / 1 000 000 | 0.043 | Iceland | Validated |
| Annual incidence | <1 / 1 000 000 | 0.018 | Ireland | Validated |
| Annual incidence | <1 / 1 000 000 | 0.037 | Italy | Validated |
| Annual incidence | <1 / 1 000 000 | 0.005 | Latvia | Validated |
| Annual incidence | <1 / 1 000 000 | 0.033 | Lithuania | Validated |
| Annual incidence | <1 / 1 000 000 | 0.016 | Norway | Validated |
| Annual incidence | <1 / 1 000 000 | 0.015 | Poland | Validated |
| Annual incidence | <1 / 1 000 000 | 0.002 | Portugal | Validated |
| Annual incidence | <1 / 1 000 000 | 0.077 | Slovakia | Validated |
| Annual incidence | <1 / 1 000 000 | 0.042 | Spain | Validated |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | squamous cell carcinoma of gallbladder and extrahepatic biliary tract |
| Mondo ID | MONDO:0018537 |
| Orphanet | 424996 |
| SNOMED CT | 766978002 |
| UMLS | C4707898 |
| MedGen | 1635098 |
| GARD | 0021792 |
| Is cancer (heuristic) | yes |
Also known as: squamous cell carcinoma of gallblader and EBT
Disease family
Classification path: human disease › disease by body system or component › digestive system disorder › digestive system cancer › liver cancer › biliary tract cancer › bile duct cancer › bile duct carcinoma › extrahepatic bile duct carcinoma › extrahepatic bile duct squamous cell carcinoma › squamous cell carcinoma of gallbladder and extrahepatic biliary tract
Related subtypes (2): ampulla of vater squamous cell carcinoma, extrahepatic bile duct adenosquamous carcinoma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.